Westlake Chemical Partners LP Announces Second Quarter 2021 Results
Westlake Chemical Partners LP (NYSE: WLKP) reported a record net income of $25.1 million for Q2 2021, a significant increase from $14.9 million in Q2 2020. This rise was driven by higher production and a buyer deficiency fee totaling $8.7 million. Operating cash flows rose to $131.7 million, up by $18.9 million year-over-year. MLP distributable cash flow also increased, reaching $25.5 million.
For the first half of 2021, net income was $40.2 million, up from $32.6 million the previous year. The company announced a quarterly distribution of $0.4714 per unit, marking its 28th consecutive distribution.
- Record Q2 2021 net income of $25.1 million, up $10.2 million year-over-year.
- Operating cash flows increased to $131.7 million, a rise of $18.9 million compared to Q2 2020.
- MLP distributable cash flow rose to $25.5 million, an increase of $8.6 million year-over-year.
- Net income for the first half of 2021 reached $40.2 million, up $7.6 million from the previous year.
- Announced a quarterly distribution of $0.4714 per unit, the 28th consecutive distribution.
- Decrease in cash flows from operating activities by $23.7 million compared to Q1 2021 due to a receivable from Westlake Chemical.
- Increased maintenance costs and turnaround reserves offset gains in MLP distributable cash flow.
Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported record net income attributable to the Partnership in the second quarter of 2021 of
Record second quarter 2021 net income attributable to the Partnership of
Net income attributable to the Partnership of
"The Partnership had a record second quarter driven by the strong consumer markets for PVC construction materials and polyethylene packaging, which drove the resulting demand for ethylene. The strong demand for ethylene and the resulting robust pricing environment drove higher margins in our second quarter 2021 third-party ethylene sales," said Albert Chao, President and Chief Executive Officer.
OpCo's Ethylene Sales Agreement with Westlake Chemical is designed to provide for stable and predictable cash flows. The agreement provides that
On August 2, 2021, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the second quarter of 2021 of
The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to cost recovery of expenses incurred in the second quarter of 2021, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to, the COVID-19 pandemic and the response thereto; operating difficulties; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake Chemical Corporation; actions of third parties; inclement or hazardous weather conditions, including flooding, and the physical impacts of climate change; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; difficulty collecting receivables; inability of our customers to take delivery; fires, explosions or other industrial accidents; our ability to borrow funds and access capital markets; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the SEC in March 2021.
This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (
Use of Non-GAAP Financial Measures
This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of income, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.
Westlake Chemical Partners LP
Westlake Chemical Partners is a limited partnership formed by Westlake Chemical Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a
Westlake Chemical Partners LP Conference Call Information:
A conference call to discuss Westlake Chemical Partners' second quarter 2021 results will be held Tuesday, August 3, 2021 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, dial (855) 765-5686 or (234) 386-2848 for international callers, approximately 10 minutes prior to the scheduled start time and reference passcode 321 65 79.
A replay of the conference call will be available beginning two hours after its conclusion until 11:59 p.m. Eastern Time on Tuesday, August 10, 2021. To hear a replay, dial (855) 859-2056 or (404) 537-3406 for international callers. The replay passcode is 321 65 79.
The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/go9q47ya and the earnings release can be obtained via the Partnership web page at: https://investors.wlkpartners.com/corporate-profile/default.aspx.
WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS") CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) |
||||||||||||||||||||
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||||||||||||||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
(In thousands of dollars, except per unit data) |
||||||||||||||||||
Revenue |
|
|
|
|
|
|
|
|
||||||||||||
Net sales—Westlake Chemical Corporation ("Westlake") |
|
$ |
240,956 |
|
|
|
$ |
227,431 |
|
|
|
$ |
460,759 |
|
|
|
$ |
442,259 |
|
|
Net co-product, ethylene and other sales—third parties |
|
81,273 |
|
|
|
11,069 |
|
|
|
129,677 |
|
|
|
46,790 |
|
|
||||
Total net sales |
|
322,229 |
|
|
|
238,500 |
|
|
|
590,436 |
|
|
|
489,049 |
|
|
||||
Cost of sales |
|
191,200 |
|
|
|
148,470 |
|
|
|
371,708 |
|
|
|
295,471 |
|
|
||||
Gross profit |
|
131,029 |
|
|
|
90,030 |
|
|
|
218,728 |
|
|
|
193,578 |
|
|
||||
Selling, general and administrative expenses |
|
8,269 |
|
|
|
6,139 |
|
|
|
16,942 |
|
|
|
12,335 |
|
|
||||
Income from operations |
|
122,760 |
|
|
|
83,891 |
|
|
|
201,786 |
|
|
|
181,243 |
|
|
||||
Other income (expense) |
|
|
|
|
|
|
|
|
||||||||||||
Interest expense—Westlake |
|
(2,224 |
) |
|
|
(3,431 |
) |
|
|
(4,460 |
) |
|
|
(7,381 |
) |
|
||||
Other income, net |
|
21 |
|
|
|
123 |
|
|
|
28 |
|
|
|
708 |
|
|
||||
Income before income taxes |
|
120,557 |
|
|
|
80,583 |
|
|
|
197,354 |
|
|
|
174,570 |
|
|
||||
Income tax provision |
|
263 |
|
|
|
206 |
|
|
|
438 |
|
|
|
423 |
|
|
||||
Net income |
|
120,294 |
|
|
|
80,377 |
|
|
|
196,916 |
|
|
|
174,147 |
|
|
||||
Less: Net income attributable to noncontrolling interests in Westlake Chemical OpCo LP ("OpCo") |
|
95,195 |
|
|
|
65,517 |
|
|
|
156,671 |
|
|
|
141,540 |
|
|
||||
Net income attributable to Westlake Partners |
|
$ |
25,099 |
|
|
|
$ |
14,860 |
|
|
|
$ |
40,245 |
|
|
|
$ |
32,607 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net income per limited partners unit attributable to Westlake Partners (basic and diluted) |
|
|
|
|
|
|
|
|
||||||||||||
Common units |
|
$ |
0.71 |
|
|
|
$ |
0.43 |
|
|
|
$ |
1.14 |
|
|
|
$ |
0.93 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Distributions declared per unit |
|
$ |
0.4714 |
|
|
|
$ |
0.4714 |
|
|
|
$ |
0.9428 |
|
|
|
$ |
0.9428 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
MLP distributable cash flow |
|
$ |
25,538 |
|
|
|
$ |
16,855 |
|
|
|
$ |
41,783 |
|
|
|
$ |
35,192 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Distributions declared |
|
|
|
|
|
|
|
|
||||||||||||
Limited partner units—publicly and privately held |
|
$ |
9,938 |
|
|
|
$ |
9,933 |
|
|
|
$ |
19,874 |
|
|
|
$ |
19,867 |
|
|
Limited partner units—Westlake |
|
6,657 |
|
|
|
6,657 |
|
|
|
13,314 |
|
|
|
13,314 |
|
|
||||
Total distributions declared |
|
$ |
16,595 |
|
|
|
$ |
16,590 |
|
|
|
$ |
33,188 |
|
|
|
$ |
33,181 |
|
|
EBITDA |
|
$ |
151,483 |
|
|
|
$ |
109,827 |
|
|
|
$ |
258,058 |
|
|
|
$ |
233,795 |
|
|
WESTLAKE CHEMICAL PARTNERS LP CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) |
||||||||||
|
|
June 30,
|
|
December 31,
|
||||||
|
|
|
|
|
||||||
|
|
(In thousands of dollars) |
||||||||
ASSETS |
|
|
|
|
||||||
Current assets |
|
|
|
|
||||||
Cash and cash equivalents |
|
$ |
17,665 |
|
|
|
$ |
17,154 |
|
|
Receivable under the Investment Management Agreement—Westlake |
|
222,249 |
|
|
|
123,228 |
|
|
||
Accounts receivable, net—Westlake |
|
66,948 |
|
|
|
108,028 |
|
|
||
Accounts receivable, net—third parties |
|
24,962 |
|
|
|
11,029 |
|
|
||
Inventories |
|
4,929 |
|
|
|
3,474 |
|
|
||
Prepaid expenses and other current assets |
|
61 |
|
|
|
392 |
|
|
||
Total current assets |
|
336,814 |
|
|
|
263,305 |
|
|
||
Property, plant and equipment, net |
|
1,030,016 |
|
|
|
1,050,677 |
|
|
||
Other assets, net |
|
34,925 |
|
|
|
42,506 |
|
|
||
Total assets |
|
$ |
1,401,755 |
|
|
|
$ |
1,356,488 |
|
|
|
|
|
|
|
||||||
LIABILITIES AND EQUITY |
|
|
|
|
||||||
Current liabilities (accounts payable and accrued liabilities) |
|
$ |
48,653 |
|
|
|
$ |
39,754 |
|
|
Long-term debt payable to Westlake |
|
399,674 |
|
|
|
399,674 |
|
|
||
Other liabilities |
|
1,670 |
|
|
|
1,923 |
|
|
||
Total liabilities |
|
449,997 |
|
|
|
441,351 |
|
|
||
Common unitholders—publicly and privately held |
|
476,076 |
|
|
|
471,701 |
|
|
||
Common unitholder—Westlake |
|
51,103 |
|
|
|
48,270 |
|
|
||
General partner—Westlake |
|
(242,572 |
) |
|
|
(242,572 |
) |
|
||
Total Westlake Partners partners' capital |
|
284,607 |
|
|
|
277,399 |
|
|
||
Noncontrolling interest in OpCo |
|
667,151 |
|
|
|
637,738 |
|
|
||
Total equity |
|
951,758 |
|
|
|
915,137 |
|
|
||
Total liabilities and equity |
|
$ |
1,401,755 |
|
|
|
$ |
1,356,488 |
|
|
WESTLAKE CHEMICAL PARTNERS LP CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) |
||||||||||
|
|
Six Months Ended June 30, |
||||||||
|
|
2021 |
|
2020 |
||||||
|
|
|
|
|
||||||
|
|
(In thousands of dollars) |
||||||||
Cash flows from operating activities |
|
|
|
|
||||||
Net income |
|
$ |
196,916 |
|
|
|
$ |
174,147 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
||||||
Depreciation and amortization |
|
56,244 |
|
|
|
51,844 |
|
|
||
Other balance sheet changes |
|
33,958 |
|
|
|
(2,272 |
) |
|
||
Net cash provided by operating activities |
|
287,118 |
|
|
|
223,719 |
|
|
||
Cash flows from investing activities |
|
|
|
|
||||||
Additions to property, plant and equipment |
|
(27,289 |
) |
|
|
(20,595 |
) |
|
||
Maturities of investments with Westlake under the Investment Management Agreement |
|
83,000 |
|
|
|
181,000 |
|
|
||
Investments with Westlake under the Investment Management Agreement |
|
(182,000 |
) |
|
|
(190,000 |
) |
|
||
Other |
|
126 |
|
|
|
— |
|
|
||
Net cash used for investing activities |
|
(126,163 |
) |
|
|
(29,595 |
) |
|
||
Cash flows from financing activities |
|
|
|
|
||||||
Quarterly distributions to noncontrolling interest retained in OpCo by Westlake |
|
(127,258 |
) |
|
|
(157,248 |
) |
|
||
Quarterly distributions to unitholders |
|
(33,186 |
) |
|
|
(33,181 |
) |
|
||
Net cash used for financing activities |
|
(160,444 |
) |
|
|
(190,429 |
) |
|
||
Net increase in cash and cash equivalents |
|
511 |
|
|
|
3,695 |
|
|
||
Cash and cash equivalents at beginning of period |
|
17,154 |
|
|
|
19,923 |
|
|
||
Cash and cash equivalents at end of period |
|
$ |
17,665 |
|
|
|
$ |
23,618 |
|
|
WESTLAKE CHEMICAL PARTNERS LP RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME AND NET CASH PROVIDED BY OPERATING ACTIVITIES (Unaudited) |
|||||||||||||||||||||||||
|
|
Three Months
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|||||||||||||||||||
|
|
2021 |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
(In thousands of dollars) |
|||||||||||||||||||||||
Net cash provided by operating activities |
|
$ |
155,408 |
|
|
|
$ |
131,710 |
|
|
|
$ |
112,758 |
|
|
|
$ |
287,118 |
|
|
|
$ |
223,719 |
|
|
Changes in operating assets and liabilities and other |
|
(78,786 |
) |
|
|
(11,416 |
) |
|
|
(32,381 |
) |
|
|
(90,202 |
) |
|
|
(49,572 |
) |
|
|||||
Net Income |
|
76,622 |
|
|
|
120,294 |
|
|
|
80,377 |
|
|
|
196,916 |
|
|
|
174,147 |
|
|
|||||
Add: |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Depreciation, amortization and disposition of property, plant and equipment |
|
28,898 |
|
|
|
28,734 |
|
|
|
26,164 |
|
|
|
57,632 |
|
|
|
52,291 |
|
|
|||||
Mark-to-market adjustment loss (gain) on derivative contracts |
|
— |
|
|
|
— |
|
|
|
704 |
|
|
|
— |
|
|
|
(1,787 |
) |
|
|||||
Less: |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Contribution to turnaround reserves |
|
(12,332 |
) |
|
|
(12,463 |
) |
|
|
(9,884 |
) |
|
|
(24,795 |
) |
|
|
(19,807 |
) |
|
|||||
Maintenance capital expenditures |
|
(11,743 |
) |
|
|
(14,344 |
) |
|
|
(8,228 |
) |
|
|
(26,087 |
) |
|
|
(19,349 |
) |
|
|||||
Distributable cash flow attributable to noncontrolling interest in OpCo |
|
(65,200 |
) |
|
|
(96,683 |
) |
|
|
(72,278 |
) |
|
|
(161,883 |
) |
|
|
(150,303 |
) |
|
|||||
MLP distributable cash flow |
|
$ |
16,245 |
|
|
|
$ |
25,538 |
|
|
|
$ |
16,855 |
|
|
|
$ |
41,783 |
|
|
|
$ |
35,192 |
|
|
WESTLAKE CHEMICAL PARTNERS LP RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND NET CASH PROVIDED BY OPERATING ACTIVITIES (Unaudited) |
|||||||||||||||||||||||||
|
|
Three Months
|
|
Three Months Ended June 30, |
|
Three Months Ended March 31, |
|||||||||||||||||||
|
|
2021 |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
(In thousands of dollars) |
|||||||||||||||||||||||
Net cash provided by operating activities |
|
$ |
155,408 |
|
|
|
$ |
131,710 |
|
|
|
$ |
112,758 |
|
|
|
$ |
287,118 |
|
|
|
$ |
223,719 |
|
|
Changes in operating assets and liabilities and other |
|
(78,786 |
) |
|
|
(11,416 |
) |
|
|
(32,381 |
) |
|
|
(90,202 |
) |
|
|
(49,572 |
) |
|
|||||
Net Income |
|
76,622 |
|
|
|
120,294 |
|
|
|
80,377 |
|
|
|
196,916 |
|
|
|
174,147 |
|
|
|||||
Less: |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Other income, net |
|
7 |
|
|
|
21 |
|
|
|
123 |
|
|
|
28 |
|
|
|
708 |
|
|
|||||
Interest expense |
|
(2,236 |
) |
|
|
(2,224 |
) |
|
|
(3,431 |
) |
|
|
(4,460 |
) |
|
|
(7,381 |
) |
|
|||||
Income tax provision |
|
(175 |
) |
|
|
(263 |
) |
|
|
(206 |
) |
|
|
(438 |
) |
|
|
(423 |
) |
|
|||||
Income from operations |
|
79,026 |
|
|
|
122,760 |
|
|
|
83,891 |
|
|
|
201,786 |
|
|
|
181,243 |
|
|
|||||
Add: |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Depreciation and amortization |
|
27,542 |
|
|
|
28,702 |
|
|
|
25,813 |
|
|
|
56,244 |
|
|
|
51,844 |
|
|
|||||
Other income, net |
|
7 |
|
|
|
21 |
|
|
|
123 |
|
|
|
28 |
|
|
|
708 |
|
|
|||||
EBITDA |
|
$ |
106,575 |
|
|
|
$ |
151,483 |
|
|
|
$ |
109,827 |
|
|
|
$ |
258,058 |
|
|
|
$ |
233,795 |
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210803005130/en/
FAQ
What was Westlake Chemical Partners' net income for Q2 2021?
How did cash flows from operating activities change in Q2 2021?
What is the MLP distributable cash flow for Q2 2021?
How much is the quarterly distribution announced for Q2 2021?